Konu "Drug Survival" için Scopus İndeksli Yayınlar Koleksiyonu listeleme
Toplam kayıt 3, listelenen: 1-3
-
Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: Results from the TURKBİO registry
(Turkiye Klinikleri, 2023)Background/aim: Adipose tissue produces several inflammatory mediators. Thus, obesity affects the disease course and the responses to the antirheumatic agents in inflammatory diseases. The aim of the study was to determine ... -
Drug survival and predictor factors for discontinuation of methotrexate in psoriasis: A real-life multicenter study
(Wiley, 2021)Background Drug survival is useful to evaluate long-term drug performance in daily practice. The aim of this study was to evaluate drug survival for methotrexate (MTX) monotherapy in patients with plaque-type psoriasis. Methods ... -
Drug survival and safety profile of acitretin monotherapy in patients with psoriasis: A multicenter retrospective study
(Wiley, 2021)Acitretin is a nonimmunosuppresive systemic agent used in the treatment of psoriasis. Despite its frequent use, research on drug survival and adverse effects is limited. This study aims to evaluate drug survival, factors ...